The Podiatry Board of Australia (the Board) has published a revised for endorsement for scheduled medicines registration standard and associated guidelines which will come into effect on 1 August 2018.

The revised standard replaces the current registration standard and will apply to podiatrists and podiatric surgeons:

  • applying to have their registration endorsed for scheduled medicines under section 94 of the National Law1, or
  • whose registration is endorsed for scheduled medicines.

To help the podiatry profession prepare for the revised standard and guidelines coming into effect they are being published in advance, together with useful FAQ and information on transitional arrangements.

For more information, please click here